SIRPA and neoplasm: It has been shown that CD47, which is highly expressed on cancer cells, and regulatory protein α (SIRPα), a macrophage expressing receptor, form checkpoints for innate immunity, inhibiting macrophage-mediated phagocytosis and leading to immune escape of tumor cells [34].